UNH vs PFE
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Pfizer, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | PFE |
|---|---|---|
| Price | $405.59 | $26.31 |
| Market cap | $364.06B | $149.96B |
| P/E ratio | 26.0 | 35.1 |
| ROE | 14.15% | 5.01% |
| Profit margin | 3.14% | 6.80% |
| Revenue growth | 0.40% | 2.60% |
| Dividend yield | 2.29% | 6.46% |
| Beta | 0.63 | 0.28 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs PFE in plain English
- UNH is the bigger company — about 2.4× the market cap of PFE.
- UNH is cheaper on earnings (P/E 26.0 vs 35.1).
- UNH earns a higher return on equity (14% vs 5%).
- PFE is growing revenue faster (3% vs 0%).
- PFE has the higher dividend yield (6.46% vs 2.29%).
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
PFE return calculator
See what $1,000 in Pfizer, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.